223 related articles for article (PubMed ID: 24610621)
1. The +252A/G polymorphism in the Lymphotoxin-α gene and the risk of non-Hodgkin lymphoma: a meta-analysis.
Cao C; Liu S; Lou SF; Liu T
Eur Rev Med Pharmacol Sci; 2014; 18(4):544-52. PubMed ID: 24610621
[TBL] [Abstract][Full Text] [Related]
2. The +252A/G polymorphism in the lymphotoxin-α gene increases the risk of asthma: a meta-analysis.
Yang M; Fu X; Zhang Y; Zhang J; He J; Tian C; Huang J; Fan H
Respirology; 2012 Nov; 17(8):1229-36. PubMed ID: 22882567
[TBL] [Abstract][Full Text] [Related]
3. Methionine synthase A2756G polymorphism and lymphoma risk: a meta-analysis.
Guo SJ; Luo SC; Liu WY; Zuo QN; Li XH
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3075-3082. PubMed ID: 28742198
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha-308 and Lymphotoxin alpha+252 genetic polymorphisms and the susceptibility to non-Hodgkin lymphoma in Egypt.
Ibrahim A; Abdel Rahman H; Khorshied M; Sami R; Nasr N; Khorshid O
Leuk Res; 2012 Jun; 36(6):694-8. PubMed ID: 22177457
[TBL] [Abstract][Full Text] [Related]
6. [Association between cytotoxic T lymphocyte protein-4 polymorphisms and non-Hodgkin's lymphoma risk: a meta-analysis].
Yi B; Pei Y; Wang C; Jiang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1099-104. PubMed ID: 27412943
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study.
Purdue MP; Lan Q; Kricker A; Grulich AE; Vajdic CM; Turner J; Whitby D; Chanock S; Rothman N; Armstrong BK
Carcinogenesis; 2007 Mar; 28(3):704-12. PubMed ID: 17056605
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.
Skibola CF; Bracci PM; Nieters A; Brooks-Wilson A; de Sanjosé S; Hughes AM; Cerhan JR; Skibola DR; Purdue M; Kane E; Lan Q; Foretova L; Schenk M; Spinelli JJ; Slager SL; De Roos AJ; Smith MT; Roman E; Cozen W; Boffetta P; Kricker A; Zheng T; Lightfoot T; Cocco P; Benavente Y; Zhang Y; Hartge P; Linet MS; Becker N; Brennan P; Zhang L; Armstrong B; Smith A; Shiao R; Novak AJ; Maynadie M; Chanock SJ; Staines A; Holford TR; Holly EA; Rothman N; Wang SS
Am J Epidemiol; 2010 Feb; 171(3):267-76. PubMed ID: 20047977
[TBL] [Abstract][Full Text] [Related]
9. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
[TBL] [Abstract][Full Text] [Related]
10. Association between Lymphotoxin Alpha (-252G/A and -804C/A) Gene Polymorphisms and Risk of Ischemic Stroke: A Meta-Analysis.
Kumar P; Misra S; Kumar A; Kishor Pandit A; Chakravarty K; Prasad K
Acta Neurol Taiwan; 2016 Mar; 25(1):10-7. PubMed ID: 27411794
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95.
Seidemann K; Zimmermann M; Book M; Meyer U; Burkhardt B; Welte K; Reiter A; Stanulla M
J Clin Oncol; 2005 Nov; 23(33):8414-21. PubMed ID: 16293872
[TBL] [Abstract][Full Text] [Related]
12. The interleukin-10-1082A>G polymorphism and lymphoma risk: a meta-analysis.
Yu X; Chen B; Cheng J; Gao C; Zhang X; Bao W
Cancer Biomark; 2014; 14(5):381-8. PubMed ID: 25171480
[TBL] [Abstract][Full Text] [Related]
13. [Association of gene polymorphisms in the DNA repair gene XPD with risk of non-Hodgkin's lymphoma].
Song B; Zhu JY; Liu J; Wang ZH; Shi Y; Lü LY; Zheng Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):97-100. PubMed ID: 18315909
[TBL] [Abstract][Full Text] [Related]
14. Association between the Lymphotoxin-
Guo S; Zuo Q; Li X; He Y; Zhou Y
Biomed Res Int; 2020; 2020():7936434. PubMed ID: 32884945
[TBL] [Abstract][Full Text] [Related]
15. The association between the polymorphisms of TNF-α and non-Hodgkin lymphoma: a meta-analysis.
He YQ; Zhu JH; Huang SY; Cui Z; He J; Jia WH
Tumour Biol; 2014 Dec; 35(12):12509-17. PubMed ID: 25204673
[TBL] [Abstract][Full Text] [Related]
16. Lymphotoxin 252A>G polymorphism is common and associates with myocardial infarction in patients with rheumatoid arthritis.
Panoulas VF; Nikas SN; Smith JP; Douglas KM; Nightingale P; Milionis HJ; Treharne GJ; Toms TE; Kita MD; Kitas GD
Ann Rheum Dis; 2008 Nov; 67(11):1550-6. PubMed ID: 18230628
[TBL] [Abstract][Full Text] [Related]
17. Associations between genetic variants in immunoregulatory genes and risk of non-Hodgkin lymphoma in a Chinese population.
Ye X; Zhao K; Wu C; Hu P; Fu H
Oncotarget; 2017 Feb; 8(6):10450-10457. PubMed ID: 28060727
[TBL] [Abstract][Full Text] [Related]
18. Effects of tumor necrosis factor-β (TNF-β) 252A>G polymorphism on the development of migraine: a meta-analysis.
Liu R; Ma M; Cui M; Dong Z; Wang X; Zhang W; Yang M; Yu S
PLoS One; 2014; 9(6):e100189. PubMed ID: 24959879
[TBL] [Abstract][Full Text] [Related]
19. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
[TBL] [Abstract][Full Text] [Related]
20. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma.
Wang SS; Cerhan JR; Hartge P; Davis S; Cozen W; Severson RK; Chatterjee N; Yeager M; Chanock SJ; Rothman N
Cancer Res; 2006 Oct; 66(19):9771-80. PubMed ID: 17018637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
